Tag Archives: drug marketing

Glaxo settles marketing fraud charges for record $3 billion

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.

Read More »

Judge upholds $327M verdict for J&J marketing

A South Carolina judge has upheld a $327 million civil penalty against health giant Johnson & Johnson, which in March was found guilty by a jury of overstating the safety and effectiveness of its former blockbuster antipsychotic drug, Risperdal.

Read More »

Justices skeptical of law barring access to Rx info

WASHINGTON – During a lively debate about doctors’ privacy rights, the justices of the U.S. Supreme Court seemed doubtful about the constitutionality of a Vermont law that gives doctors the right to refuse to provide prescription drug records to drug ...

Read More »